Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

GSK gets Japan approval for prefilled Shingrix vaccine

10th Sep 2026 09:26

(Alliance News) - GSK PLC on Thursday said its Shingrix shingles vaccine has been approved by Japan's Ministry of Health, Labour & Welfare. Read More

LONDON BROKER RATINGS: RBC prefers Astra to GSK; HSBC cuts Burberry

9th Sep 2026 09:04

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET CLOSE: FTSE 100 slips as Bailey flags inflation risks

8th Sep 2026 17:10

(Alliance News) - Stock prices in London closed lower on Tuesday, as Bank of England Governor Andrew Bailey warned of upside inflation risks amid elevated energy prices, while Computacenter reversed an early rally to finish at the bottom of the FTSE 100. Read More

LONDON BROKER RATINGS: Jefferies raises Autotrader and Rightmove

8th Sep 2026 09:08

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON MARKET MIDDAY: FTSE 100 edges higher; oil rises above USD97

3rd Sep 2026 12:10

(Alliance News) - Stock prices in London were higher at midday on Thursday, as gains for telecom stocks helped the FTSE 100 edge into positive territory, while investors digested stronger UK services activity and rising inflationary pressures in Europe. Read More

WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit

3rd Sep 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830

3rd Sep 2026 10:22

(Alliance News) - Hutchmed China PLC on Thursday announced that its subsidiary, Hutchmed Ltd, has entered into an exclusive development licence agreement with a subsidiary of GSK PLC. Read More

LONDON BRIEFING: LondonMetric investments; Jet2 eyes Main Market move

3rd Sep 2026 07:56

(Alliance News) - M&G swings to a first-half pretax loss attributable to equity holders as short-term investment fluctuations weigh on statutory results, while LondonMetric Property announces GBP105 million of investment activity. Elsewhere, Jet2 says trading remains strong and announces plans to move from AIM to London's Main Market. Read More

GSK advances mRNA flu vaccine to phase 3 after positive results

1st Sep 2026 11:23

(Alliance News) - GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate showed positive results and that phase 3 trials will start this month. Read More

LONDON BRIEFING: UK house prices subdued; Bunzl lifts outlook

1st Sep 2026 07:58

(Alliance News) - UK house price growth remains subdued in August despite a modest monthly recovery. Bunzl upgrades its full-year outlook and announces a GBP500 million share buyback, while Bodycote and Gamma Communications accept takeover offers. Read More

LONDON MARKET CLOSE: FTSE down as inflation fear offsets Nvidia lift

27th Aug 2026 17:01

(Alliance News) - The FTSE 100 faltered on Thursday, despite technology focused stocks getting a boost from Nvidia, with investors wary ahead of Kevin Warsh's speech at Jackson Hole. Read More

LONDON MARKET CLOSE: FTSE 100 outperforms as oil price heads lower

24th Aug 2026 17:04

(Alliance News) - The FTSE 100 closed higher in London on Monday, outperforming European peers, as oil prices edged lower and investors looked ahead to key events in the US later this week. Read More

IN BRIEF: GSK US President sells shares worth USD2.3 million

24th Aug 2026 16:50

GSK PLC - London-based pharmaceutical firm - President of the US business Maya Martinez-Davis sells 3,916 American depository receipts at an average price of USD52.14 each, worth approximately GBP204,180 in total, on Thursday in New York. On Friday, Martinez-Davis sells 40,481 ADRs, also at an average USD52.14 each, worth about USD2.1 million. Read More

GSK gets hepatitis approval in Japan, fast US review in rectal cancer

24th Aug 2026 09:20

(Alliance News) - GSK PLC on Monday reported two positive regulatory developments for its treatments of hepatitis and rectal cancer. Read More

LONDON BRIEFING: GSK drug approved in Japan; Tracsis trading in-line

24th Aug 2026 07:59

(Alliance News) - The FTSE 100 was called slightly higher on Monday, following news of US President Donald Trump's intention to wage a "crushing" financial operation against Iran. Read More

WINNERS & LOSERS: Hunting falls on outlook cut; miners rise

21st Aug 2026 09:40

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

Chugai grants GSK exclusive global license for AID351 dengue antibody

18th Aug 2026 04:32

(Alliance News) - Chugai Pharmaceutical Co Ltd on Tuesday announced it has signed an exclusive global license agreement with London-based pharmaceuticals maker GSK PLC. Read More

LONDON MARKET CLOSE: FTSE 100 drifts lower as oil price pushes higher

17th Aug 2026 17:07

(Alliance News) - Stocks in London closed in the red on Monday, with fresh gains in the oil price and a lack of new catalysts curbing enthusiasm. Read More

LONDON MARKET CLOSE: FTSE 100 drifts lower in mixed day for Europe

14th Aug 2026 17:07

(Alliance News) - Stocks in London closed mixed on Friday, with weak mining and pharmaceutical stocks dragging the blue-chip FTSE 100 lower, but mid-caps posting modest gains. Read More

LONDON MARKET MIDDAY: FTSE 100 underwhelms in tepid end to week

14th Aug 2026 12:06

(Alliance News) - London's FTSE 100 underperformed continental peers on Friday, with software shares rising but impetus lacking elsewhere, leaving the blue-chip benchmark set for a weekly decline. Read More

FTSE 100 Latest
Value10,650.44
Change41.52